Literature DB >> 21045701

Pathogenesis of IgG4-related disease.

Yoh Zen1, Yasuni Nakanuma.   

Abstract

PURPOSE OF REVIEW: To review studies that have examined underlying genetic and immunological aspects of IgG4-related disease. RECENT
FINDINGS: Genetic studies have suggested that several human leukocyte antigen (HLA) and non-HLA haplotypes/genotypes are associated with susceptibility to IgG4-related disease or to disease relapse after steroid therapy. Among several autoantibodies identified so far, autoantibodies against lactoferrin and carbonic anhydrase II are most frequently detected in serum of IgG4-disease patients. However, it has not been well clarified whether or not those autoantibodies belong to an IgG4 subclass. Studies that have demonstrated molecular mimicry between Helicobacter pylori and constituents of pancreatic epithelial cells suggest that gastric H. pylori infection triggers autoimmune pancreatitis in genetically predisposed individuals through antibody cross-reactivity. Recently, T-helper 2 immune reaction has been suggested to be predominant in IgG4-related disease. Interestingly, regulatory immune reactions are activated in IgG4-related disease, and regulatory cytokines interleukin-10 and transforming growth factor-b have been suggested, respectively, to play important roles in IgG4 class switch and fibroplasia.
SUMMARY: Autoimmunity has been considered the most probable pathogenesis of IgG4-related disease, but has not been completely proved so far. A breakthrough study to detect a specific autoantigen, autoantibody, or pathogen is necessary.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21045701     DOI: 10.1097/BOR.0b013e3283412f4a

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  39 in total

1.  Autoimmune pancreatitis characterized by predominant CD8+ T lymphocyte infiltration.

Authors:  She-Yu Li; Xiang-Yang Huang; Yong-Tao Chen; Yi Liu; Sha Zhao
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

Review 2.  The great mimicker: IgG4-related disease.

Authors:  Rodolfo Perez Alamino; Luis R Espinoza; Arnold H Zea
Journal:  Clin Rheumatol       Date:  2013-07-23       Impact factor: 2.980

Review 3.  IgG-4 Related Disease: An Introduction.

Authors:  Orwah M Al-Khalili; Alan R Erickson
Journal:  Mo Med       Date:  2018 May-Jun

Review 4.  IgG4-related nephropathy.

Authors:  Giacomo Quattrocchio; Dario Roccatello
Journal:  J Nephrol       Date:  2016-03-14       Impact factor: 3.902

5.  The rare case report of interstitial lung disease with normal serum level of IgG4 developed six years after treatment of autoimmune pancreatitis.

Authors:  Tatjana Adzic-Vukicevic; Jelena Stojsic; Aleksandra Barac; Ana Blanka Protic; Sladjana Andrejevic; Snezana Raljevic
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 6.  IgG4-related disease and the kidney.

Authors:  Frank B Cortazar; John H Stone
Journal:  Nat Rev Nephrol       Date:  2015-06-30       Impact factor: 28.314

7.  Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.

Authors:  Zachary S Wallace; Hamid Mattoo; Mollie Carruthers; Vinay S Mahajan; Emanuel Della Torre; Hang Lee; Maria Kulikova; Vikram Deshpande; Shiv Pillai; John H Stone
Journal:  Ann Rheum Dis       Date:  2014-05-09       Impact factor: 19.103

Review 8.  Concomitant occurrence of IgG4-related pleuritis and periaortitis: a case report with review of the literature.

Authors:  Mitsuaki Ishida; Keiko Hodohara; Aya Furuya; Aya Fujishiro; Hiroko Okuno; Miyuki Yoshii; Akiko Horinouchi; Ayaka Shirakawa; Ayumi Harada; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Takashi Yoshida; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 9.  [IgG4-related disease].

Authors:  J Loock; B Manger
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

10.  Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice.

Authors:  J Kärner; A Meager; M Laan; J Maslovskaja; M Pihlap; A Remm; E Juronen; A S B Wolff; E S Husebye; K T Podkrajšek; N Bratanic; T Battelino; N Willcox; P Peterson; K Kisand
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.